TUMOR INFILTRATING LYMPHOCYTES
Clinical trials for TUMOR INFILTRATING LYMPHOCYTES explained in plain language.
Never miss a new study
Get alerted when new TUMOR INFILTRATING LYMPHOCYTES trials appear
Sign up with your email to follow new studies for TUMOR INFILTRATING LYMPHOCYTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test Gene-Edited 'Living Drug' against deadly pancreatic cancer
Disease control Recruiting nowThis early-stage study is testing whether specially engineered immune cells can help control advanced pancreatic cancer. Doctors take immune cells from a patient's own tumor, modify them in the lab to potentially fight cancer better, then infuse them back into the patient. The tr…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Scientists test modified immune cells to fight advanced cancers
Disease control Recruiting nowThis early study tests a new immune cell therapy for people with advanced solid tumors who haven't responded to standard treatments. Doctors collect and grow tumor-fighting immune cells from each patient's own tumor, modify them, and infuse them back into the patient. The study a…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC